HOME
Hepatitis B
Hepatitis C
HIV and AIDS
HIV-HCV Coinfection
HIV-HBV Coinfection
Hepatitis B Main Section
FDA-approved Treatments
 Experimental Treatments
 HBV Articles by Topic

Emtricitabine; FTC for HBV


Long-term Adefovir (Hepsera) plus Emtricitabine (Emtriva) vs Adefovir Monotherapy for Chronic Hepatitis - 4/18/08

HAART Regimens Containing Tenofovir Plus Lamivudine or Emtricitabine Work Best for HIV-HBV Coinfected Patients  - 5/01/07

Outcomes in HIV-HBV Coinfected Patients Treated with Drugs Active Against Both Viruses 10/17/06

Antiviral Response and Resistance Surveillance for HBeAg-negative Patients in a Study Evaluating Emtricitabine Plus Clevudine versus Emtricitabine Monotherapy - 11/21/05

Once Daily Emtricitabine Produces a Reduction in Inflammation and Fibrosis in Patients with Chronic Hepatitis B - 11/24/04

 

 

 

 

 

 

 

 

 

 

 

 

 

 


HBV Articles on
FDA-approved Therapies
for Chronic HBV Infection

Baraclude  (entecavir)
 Epivir-HBV  (lamivudine; 3TC)
 Hepsera   (adefovir dipivoxil)
Intron A  (interferon alfa-2b)
Pegasys  (peginterferon alfa-2a)
 Tyzeka   (telbivudine)